Emmessar Biotech and Nutrition Ltd
BSE:524768
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Emmessar Biotech and Nutrition Ltd
BSE:524768
|
IN |
|
Shenzhen Sunway Communication Co Ltd
SZSE:300136
|
CN |
|
Paragon Banking Group PLC
LSE:PAG
|
UK |
|
A
|
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
|
CN |
|
Beijing Oriental Yuhong Waterproof Technology Co Ltd
SZSE:002271
|
CN |
|
W
|
Wuxi ETEK Microelectronics Co Ltd
SSE:688601
|
CN |
|
Sharda Cropchem Ltd
NSE:SHARDACROP
|
IN |
|
K
|
KPS AG
XETRA:KSC
|
DE |
|
Salmon Evolution ASA
OSE:SALME
|
NO |
|
H
|
Hennessy Capital Investment Corp VI
NASDAQ:HCVI
|
US |
|
Bringspring Science and Technology Co Ltd
SZSE:300290
|
CN |
|
Kencana Energi Lestari Tbk PT
IDX:KEEN
|
ID |
|
Columbus A/S
F:P1F
|
DK |
|
Vista Outdoor Inc
NYSE:VSTO
|
US |
|
J
|
Jbs NV
NYSE:JBS
|
NL |
|
Infinity Logistics and Transport Ventures Ltd
HKEX:1442
|
MY |
|
Mercedes-Benz Group AG
XETRA:MBG
|
DE |
|
Inventure Growth & Securities Ltd
NSE:INVENTURE
|
IN |
Discount Rate
EMMESSA Cost of Equity
Discount Rate
EMMESSA's Cost of Equity, calculated using the formula
Risk-Free Rate + Beta x ERP,
stands at 11.06%.
The Beta, indicating the stock's volatility relative to the market, is 0.97, while the current Risk-Free Rate, based on government bond yields, is 7%, and the ERP, measuring the extra return over the risk-free rate required by investors, is 4.18%.
EMMESSA WACC
Discount Rate
EMMESSA's Weighted Average Cost of Capital (WACC) is calculated as the weighted average of its cost of equity and cost of debt, adjusted for tax.
The WACC stands at 11.06%. This includes the cost of equity at 11.06%, calculated as Risk-Free Rate + Beta x ERP, and the cost of debt at 8.39%, reflecting the interest rate on
EMMESSA's debt adjusted for tax benefits. The weight of debt in the capital structure is 0%.
What is EMMESSA's discount rate?
EMMESSA
's current Cost of Equity is 11.06%, while its WACC stands at 11.06%.
The selection of the appropriate discount rate is contingent on the type of cash flows being discounted.
For Equity Valuation: When valuing equity, especially in scenarios where you are discounting cash flows to equity holders (such as Net Income, Earnings Per Share (EPS), or Free Cash Flow to Equity), the Cost of Equity should be used.
For Firm Valuation: In contrast, when valuing the entire firm and discounting cash flows available to both debt and equity holders (like Free Cash Flow to the Firm), the Weighted Average Cost of Capital (WACC) is the appropriate rate."
How is Cost of Equity for EMMESSA calculated?
The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP).
This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk.
Here is how we calculate the cost of equity for
EMMESSA
How is WACC for EMMESSA calculated?
WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company’s entire operations.
The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure.
Here is how we calculate WACC for
EMMESSA
